Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged intellectual property infringemen…
8 months, 1 week ago
Pharmaceutical Executive Daily: George Tidmarsh Resigns from FDA
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s plan to submit its oral GLP-1 candidate for FDA priority review, the departure of sen…
8 months, 1 week ago
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s unsolicited proposal to acquire Metsera, renewed legal action against Tylenol’s ma…
8 months, 2 weeks ago
Pharmaceutical Executive Daily: Thermo Fisher's $8.8 Billion Acquisition of Clario Holdings
In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli Lilly’s partnership with Wal…
8 months, 2 weeks ago
Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in…
8 months, 2 weeks ago
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sa…
8 months, 2 weeks ago
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic m…
8 months, 2 weeks ago
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug commercialization, new …
8 months, 3 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life Sciences’ acquisition of BPD He…
8 months, 3 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up
In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to reject a petition calli…
8 months, 3 weeks ago